Stockreport

BeiGene (NasdaqGS:ONC) Gains 32% In A Quarter Amid Positive EMA Opinion On TEVIMBRA [Yahoo! Finance]

ImmunityBio, Inc.  (IBRX) 
PDF The company's positive momentum can be attributed to the European Medicines Agency's positive opinion on TEVIMBRA, recommended for small cell lung cancer treatment, and [Read more]